谷歌浏览器插件
订阅小程序
在清言上使用

Biomarker summary analysis for the histone deacetylase inhibitor resminostat – review and conclusions based on three oncology phase I and phase II trials

T. Herz, A.S. Ammendola,R. Baumgartner

EUROPEAN JOURNAL OF CANCER(2016)

引用 0|浏览7
暂无评分
关键词
histone deacetylase inhibitor resminostat,histone deacetylase,oncology phase
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要